Novartis invests in bispecifics for cancer; Bob Langer steps down from Moderna board

Retrieved on: 2024-07-24 21:33:59

Tags for this article:

Click the tags to see associated articles and topics

Novartis invests in bispecifics for cancer; Bob Langer steps down from Moderna board. View article details on hiswai:

Excerpt

Don't miss tomorrow's biopharma industry news · Novartis invests in bispecifics for cancer; Bob Langer steps down from Moderna board.

Article found on: www.biopharmadive.com